Pharvaris N.V.
PHVS
$23.65
$0.532.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.00% | -19.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.21% | -7.64% | |||
| Operating Income | -3.21% | 7.64% | |||
| Income Before Tax | -6.07% | -35.58% | |||
| Income Tax Expenses | -27.76% | -75.89% | |||
| Earnings from Continuing Operations | -5.85% | -31.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.85% | -31.61% | |||
| EBIT | -3.21% | 7.64% | |||
| EBITDA | -3.20% | 7.66% | |||
| EPS Basic | -5.45% | -31.21% | |||
| Normalized Basic EPS | -5.69% | -35.17% | |||
| EPS Diluted | -5.45% | -31.21% | |||
| Normalized Diluted EPS | -5.69% | -35.17% | |||
| Average Basic Shares Outstanding | 0.37% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.37% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||